Similarly, in osteoarthritis (OA), elevated TGF-β levels in subchondral bone lead to pathological changes; targeted inhibition has been shown to attenuate OA progression by normalizing bone remodeling [41]. Here, TGFB1 is linked to osteoarthritis.